Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Analysis of Long-term (Investment) Activity Ratios 

Microsoft Excel

Long-term Activity Ratios (Summary)

Bristol-Myers Squibb Co., long-term (investment) activity ratios

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net fixed asset turnover 7.67 7.22 4.18 4.49 4.15
Net fixed asset turnover (including operating lease, right-of-use asset) 6.66 6.30 3.76 4.49 4.15
Total asset turnover 0.42 0.36 0.20 0.64 0.62
Equity turnover 1.29 1.12 0.51 1.61 1.77

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Bristol-Myers Squibb Co. net fixed asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021.
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Bristol-Myers Squibb Co. net fixed asset turnover ratio (with operating lease, right-of-use asset) improved from 2019 to 2020 and from 2020 to 2021.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Bristol-Myers Squibb Co. total asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Bristol-Myers Squibb Co. equity turnover ratio improved from 2019 to 2020 and from 2020 to 2021.

Net Fixed Asset Turnover

Bristol-Myers Squibb Co., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Revenues 46,385 42,518 26,145 22,561 20,776
Property, plant and equipment 6,049 5,886 6,252 5,027 5,001
Long-term Activity Ratio
Net fixed asset turnover1 7.67 7.22 4.18 4.49 4.15
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 4.81 3.83 3.97 4.04 3.60
Abiomed Inc. 4.30 5.10 5.31 5.07 5.07
Cigna Corp. 46.73 37.85 34.45 10.34 25.96
CVS Health Corp. 22.56 21.25 21.24 17.09 17.95
Danaher Corp. 7.77 6.83 7.78 7.92 7.47
Elevance Health Inc. 34.94 34.69 32.92 33.40 40.95
Humana Inc. 26.97 32.05 32.93 32.51 33.69
Intuitive Surgical Inc. 3.04 2.76 3.52 4.59 5.10
Medtronic PLC 5.77 5.99 6.54 6.51 6.81
UnitedHealth Group Inc. 31.81 29.64 27.60 26.59 28.54
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services 19.17 18.08 17.52 14.57 15.62
Net Fixed Asset Turnover, Industry
Health Care 10.27 9.48 9.59 8.39 8.43

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Net fixed asset turnover = Revenues ÷ Property, plant and equipment
= 46,385 ÷ 6,049 = 7.67

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Bristol-Myers Squibb Co. net fixed asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021.

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Bristol-Myers Squibb Co., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Revenues 46,385 42,518 26,145 22,561 20,776
 
Property, plant and equipment 6,049 5,886 6,252 5,027 5,001
Operating lease right-of-use assets 919 859 704
Property, plant and equipment (including operating lease, right-of-use asset) 6,968 6,745 6,956 5,027 5,001
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1 6.66 6.30 3.76 4.49 4.15
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories 4.26 3.42 3.56 4.04 3.60
Abiomed Inc. 4.17 4.76 5.31 5.07 5.07
Cigna Corp. 41.37 33.46 30.72 10.34 25.96
CVS Health Corp. 9.09 8.04 7.77 17.09 17.95
Danaher Corp. 6.10 5.30 5.84 7.92 7.47
Elevance Health Inc. 30.12 29.26 27.82 33.40 40.95
Humana Inc. 22.09 27.07 27.22 32.51 33.69
Intuitive Surgical Inc. 2.93 2.66 3.32 4.59 5.10
Medtronic PLC 4.84 5.02 6.54 6.51 6.81
UnitedHealth Group Inc. 21.54 19.55 18.97 26.59 28.54
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services 12.77 11.68 11.35 14.57 15.62
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care 8.17 7.46 7.55 8.39 8.43

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenues ÷ Property, plant and equipment (including operating lease, right-of-use asset)
= 46,385 ÷ 6,968 = 6.66

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Bristol-Myers Squibb Co. net fixed asset turnover ratio (with operating lease, right-of-use asset) improved from 2019 to 2020 and from 2020 to 2021.

Total Asset Turnover

Bristol-Myers Squibb Co., total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Revenues 46,385 42,518 26,145 22,561 20,776
Total assets 109,314 118,481 129,944 34,986 33,551
Long-term Activity Ratio
Total asset turnover1 0.42 0.36 0.20 0.64 0.62
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.57 0.48 0.47 0.46 0.36
Abiomed Inc. 0.57 0.69 0.73 0.76 0.81
Cigna Corp. 1.11 1.02 0.98 0.31 0.66
CVS Health Corp. 1.25 1.16 1.15 0.99 1.94
Danaher Corp. 0.35 0.29 0.29 0.42 0.39
Elevance Health Inc. 1.41 1.39 1.33 1.28 1.26
Humana Inc. 1.87 2.17 2.21 2.22 1.96
Intuitive Surgical Inc. 0.42 0.39 0.46 0.47 0.54
Medtronic PLC 0.32 0.32 0.34 0.33 0.30
UnitedHealth Group Inc. 1.34 1.30 1.38 1.48 1.44
Total Asset Turnover, Sector
Health Care Equipment & Services 1.01 0.94 0.91 0.85 1.02
Total Asset Turnover, Industry
Health Care 0.75 0.70 0.71 0.66 0.68

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Total asset turnover = Revenues ÷ Total assets
= 46,385 ÷ 109,314 = 0.42

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Bristol-Myers Squibb Co. total asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021.

Equity Turnover

Bristol-Myers Squibb Co., equity turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Revenues 46,385 42,518 26,145 22,561 20,776
Total Bristol-Myers Squibb Company shareholders’ equity 35,946 37,822 51,598 14,031 11,741
Long-term Activity Ratio
Equity turnover1 1.29 1.12 0.51 1.61 1.77
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 1.20 1.06 1.03 1.00 0.89
Abiomed Inc. 0.64 0.79 0.82 0.86 0.99
Cigna Corp. 3.66 3.16 3.36 1.15 2.96
CVS Health Corp. 3.87 3.86 4.00 3.33 4.90
Danaher Corp. 0.65 0.56 0.59 0.71 0.70
Elevance Health Inc. 3.80 3.64 3.25 3.20 3.36
Humana Inc. 5.15 5.54 5.35 5.55 5.42
Intuitive Surgical Inc. 0.48 0.45 0.54 0.56 0.66
Medtronic PLC 0.59 0.57 0.61 0.59 0.59
UnitedHealth Group Inc. 3.98 3.90 4.17 4.35 4.19
Equity Turnover, Sector
Health Care Equipment & Services 2.63 2.51 2.42 2.25 2.57
Equity Turnover, Industry
Health Care 2.08 2.06 2.05 1.88 1.83

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Equity turnover = Revenues ÷ Total Bristol-Myers Squibb Company shareholders’ equity
= 46,385 ÷ 35,946 = 1.29

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Bristol-Myers Squibb Co. equity turnover ratio improved from 2019 to 2020 and from 2020 to 2021.